A recent whole-genome methylation profiling analysis, however, did find a hypomethylation in an alternative promoter of LIN28B that was correlated with increased LIN28B expression particularly in Group 3 and Group 4 medulloblastomas [8]. The gene discussed is LIN28B; the disease is medulloblastoma.